We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+19.44%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$28.4B
AUM Growth
+$3.28B
(+13%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
22.69%
Holding
696
New
203
Increased
144
Reduced
156
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$382M |
| 2 |
JPMorgan Chase
JPM
|
+$330M |
| 3 |
Arista Networks
ANET
|
+$263M |
| 4 |
Zebra Technologies
ZBRA
|
+$217M |
| 5 |
Walt Disney
DIS
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$366M |
| 2 |
Cisco
CSCO
|
+$309M |
| 3 |
United Airlines
UAL
|
+$265M |
| 4 |
Western Digital
WDC
|
+$196M |
| 5 |
Medtronic
MDT
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Consumer Discretionary | 10.61% |
| 3 | Industrials | 10.56% |
| 4 | Healthcare | 9.33% |
| 5 | Financials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Eledon Pharmaceuticals
ELDN
$284M
| $2.53M | 0.01% |
933,475
| – | – |
|
|
KRMN
477
Karman Holdings
KRMN
$8.24B
| $2.52M | 0.01% |
50,000
-100,000
| -67% | -$4.02M |
|
478
Kymera Therapeutics
KYMR
$9.03B
| $2.18M | 0.01% |
+50,000
| New | +$1.72M |
|
|
AVR
479
Anteris Technologies
AVR
$872M
| $2.08M | 0.01% |
550,000
| – | – |
|
480
MasTec
MTZ
$21.5B
| $2.07M | 0.01% |
+12,117
| New | +$1.75M |
|
481
Manhattan Associates
MANH
$11.4B
| $1.98M | 0.01% |
+10,045
| New | +$1.82M |
|
482
Skye Bioscience
SKYE
$18.7M
| $1.91M | 0.01% |
456,163
| – | – |
|
483
Johnson Controls International
JCI
$91.3B
| $1.84M | 0.01% |
+17,424
| New | +$1.6M |
|
|
MTSR
484
DELISTED
Metsera Inc
MTSR
| $1.56M | 0.01% |
+55,000
| New | +$1.37M |
|
|
WAY
485
Waystar Holding Corp
WAY
$4.74B
| $1.54M | 0.01% |
+37,669
| New | +$1.45M |
|
|
MAZE
486
Maze Therapeutics
MAZE
$1.51B
| $1.53M | 0.01% |
125,000
| – | – |
|
|
URG
487
Ur-Energy
URG
$564M
| $1.53M | 0.01% |
1,454,894
| – | – |
|
488
Masco
MAS
$14.7B
| $1.47M | 0.01% |
+22,915
| New | +$1.44M |
|
489
Webster Financial
WBS
$12.8B
| $1.47M | 0.01% |
+26,952
| New | +$1.34M |
|
490
Arcturus Therapeutics
ARCT
$200M
| $1.33M | ﹤0.01% |
+102,518
| New | +$1.21M |
|
|
KLC
491
KinderCare Learning Companies
KLC
$596M
| $1.31M | ﹤0.01% |
+129,497
| New | +$1.5M |
|
492
Roivant Sciences
ROIV
$25.8B
| $1.31M | ﹤0.01% |
+115,866
| New | +$1.26M |
|
493
Health Catalyst
HCAT
$127M
| $1.3M | ﹤0.01% |
346,089
-3,105
| -0.9% | -$12.2K |
|
|
ASIC
494
Ategrity Specialty Insurance
ASIC
$1.19B
| $1.29M | ﹤0.01% |
+60,000
| New | +$1.37M |
|
495
Allot
ALLT
$369M
| $1.28M | ﹤0.01% |
+150,000
| New | +$1.08M |
|
496
monday.com
MNDY
$3.75B
| $1.28M | ﹤0.01% |
4,060
+407
| +11% | +$113K |
|
|
KMTS
497
Kestra Medical Technologies
KMTS
$1.66B
| $1.24M | ﹤0.01% |
75,000
-25,000
| -25% | -$546K |
|
498
Modular Medical
MODD
$10.8M
| $1.17M | ﹤0.01% |
52,232
-4,712
| -8% | -$126K |
|
499
P3 Health Partners
PIII
$42.7M
| $1.14M | ﹤0.01% |
180,906
-1
| -0% | -$8 |
|
|
BBNX
500
Beta Bionics
BBNX
$738M
| $1.09M | ﹤0.01% |
75,000
| – | – |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2025 Portfolio in Review
As of Q2 2025, Alyeska Investment Group held 696 positions worth $28.4B, up 13% from $25.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Alyeska Investment Group's Q2 2025 filing shows 203 new, 144 increased, 156 reduced and 154 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,335,726 shares worth $412M. The largest sale was Amazon, an estimated $366M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q2 2025 buy was Alphabet (Google) Class A: 2,335,726 shares worth $412M.
- Alyeska Investment Group added most to JPMorgan Chase in Q2 2025, an estimated $330M increase.
- Alyeska Investment Group's biggest Q2 2025 reduction was Amazon, cutting an estimated $366M.
- Alyeska Investment Group fully exited Sherwin-Williams in Q2 2025, selling an estimated $188M.
- Alyeska Investment Group's ten largest holdings make up 23% of its $28.4B portfolio in Q2 2025.
- Alyeska Investment Group opened 203 new positions and closed 154 in Q2 2025.
- Alyeska Investment Group's portfolio value rose 13% quarter-over-quarter to $28.4B.
Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.